Identification of unapproved orthopedic regenerative medicine: Usefulness of the Act on Safety of Regenerative Medicine

被引：1

作者：

Ukon, Yuichiro ^{[1
]}

Hosoya, Satoshi ^{[2
]}

Morita, Kazuki ^{[3
]}

Yokozeki, Yuji ^{[4
]}

Kataoka, Tomoko ^{[5
]}

Kitahara, Takayuki ^{[1
]}

Mae, Hirokazu ^{[1
]}

Kanie, Yuya ^{[1
]}

Furuya, Masayuki ^{[1
]}

Fujimori, Takahito ^{[1
]}

Kaito, Takashi ^{[1
]}

Okada, Kiyoshi ^{[6
]}

Myoui, Akira ^{[7
]}

Okada, Seiji ^{[1
]}

机构：

[1] Osaka Univ, Grad Sch Med, Dept Orthopaed Surg, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan

[2] Jikei Univ, Sch Med, Dept Obstet & Gynecol, 3-25-8 Nishishinbashi,Minato Ku, Tokyo 1058461, Japan

[3] Tokyo Med & Dent Univ TMDU, Grad Sch Med & Dent Sci, Dept Periodontol, 1-5-45,Yushima,Bunkyo Ku, Tokyo 1138510, Japan

[4] Kitasato Univ, Sch Med, Dept Orthopaed Surg, 1-15-1 Kitasato,Minami Ku, Sagamihara, Kanagawa 2520374, Japan

[5] Natl Canc Ctr, Clin Res Support Off, 5-1-1 Tsukiji,Chuo Ku, Tokyo 1040045, Japan

[6] Osaka Univ, X innovat Comm Hlth & Med, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan

[7] Osaka Univ Hosp, Dept Med Innovat, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan

来源：

STEM CELL REPORTS | 2024年 / 19卷 / 05期

关键词：

D O I：

10.1016/j.stemcr.2024.04.001

中图分类号：

Q813 [细胞工程];

学科分类号：

摘要：

In Japan, the Act on Safety of Regenerative Medicine regulates unapproved regenerative medicine. Other nations market regenerative medicine products, bypassing regulatory approval. To identify unapproved orthopedic regenerative medicine, we have used data based on the Act. Platelet-rich plasma was often used. The common target was the knee. Prices averaged $2,490.

引用

页码：597 / 603

页数：7

共 50 条

[1] Japan's challenges of translational regenerative medicine: Act on the safety of regenerative medicine
Tobita, Morikuni
Konomi, Kenji
Torashima, Yasuhiro
Kimura, Kenichi
Taoka, Masaomi
Kaminota, Masahiro
[J]. REGENERATIVE THERAPY, 2016, 4 : 78 - 81
[2] Regenerative medicine in Obstetrics & Gynecology: Current status under the Act on the Safety of Regenerative Medicine in Japan
Hosoya, Satoshi
Awano-Kim, Sena
Yokomizo, Ryo
Ukon, Yuichirou
Morita, Kazuki
Kasahara, Yuta
Kishi, Hiroshi
Okamoto, Aikou
[J]. REGENERATIVE THERAPY, 2024, 26 : 564 - 570
[3] Marketing of Unproven and Unapproved Regenerative Medicine Therapies
Rodeo, Scott A.
[J]. SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH, 2024, 16 (03): : 312 - 314
[4] Collagen Scaffolds for Orthopedic Regenerative Medicine
Cunniffe, Grainne M.
O'Brien, Fergal J.
[J]. JOM, 2011, 63 (04) : 66 - 73
[5] Collagen scaffolds for orthopedic regenerative medicine
Gráinne M. Cunniffe
Fergal J. O’Brien
[J]. JOM, 2011, 63
[6] Innovations in Orthopedic Biomaterials and Regenerative Medicine in China
Ouyang, Hongwei
[J]. ACS BIOMATERIALS SCIENCE & ENGINEERING, 2021, 7 (03): : 804 - 805
[7] Regenerative Medicine in Orthopedic Surgery: Expanding Our Toolbox
Ibrahim, Ayah
Gupton, Marco
Schroeder, Frederick
[J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (09)
[8] Incorporating Regenerative Medicine Techniques is an Outpatient Orthopedic Setting
Lox, D.
[J]. CELL TRANSPLANTATION, 2011, 20 (04) : 571 - 571
[9] Epigenetics as a New Frontier in Orthopedic Regenerative Medicine and Oncology
van Wijnen, Andre J.
Westendorf, Jennifer J.
[J]. JOURNAL OF ORTHOPAEDIC RESEARCH, 2019, 37 (07) : 1465 - 1474
[10] Regenerative Medicine
Glotzbach, Jason P.
Wong, Victor W.
Gurtner, Geoffrey C.
Longaker, Michael T.
[J]. CURRENT PROBLEMS IN SURGERY, 2011, 48 (03) : 148 - 212

← 1 2 3 4 5 →